Home Top Movers Histogen Inc. (HSTO) stock plunged during pre-market trading. What’s driving it low?

Histogen Inc. (HSTO) stock plunged during pre-market trading. What’s driving it low?

Histogen Inc. (NASDAQ: HSTO) stock gained by 16.16% at last close whereas the HSTO stock price declines by 2.73% in the pre-market trading. Histogen Inc. is a clinical-stage pharmaceuticals business focusing on creating potentially first-in-class restorative medicines that activate the body’s inherent repair and maintenance processes.

>> 7 Top Picks for the Post-Pandemic Economy << 

Current Update

HSTO released the top-line findings of HSTO’s Phase 1 trial of emricasan in mild symptomatic COVID-19 patients to assess safety, tolerability, and preliminary effectiveness. In comparison to the placebo, emricasan was shown to be safe and well tolerated over the 14-day dosing period and at the 45-day follow-up, with no major side events reported. At day 7, patients who finished emricasan treatment experienced a full remission of the symptoms most often associated with moderate COVID-19, such as cough, headache, and fatigue, which lasted until day 45. COVID-19 symptom remission was not observed in patients in the placebo group who completed the study until day 45.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Read More

In addition, a number of critical observations on clinical outcomes, laboratory results, and drug target-related biomarkers were made. Individuals in the active medication group had positive changes in their caspase biomarkers, but patients in the placebo group remained to exhibit COVID-19-related symptoms and laboratory results.

Official Statements

Raavi Gupta, M.D. Associate Professor and the Principal Investigator at SUNY Downstate Health Sciences University said that the safety and potential therapeutic value of emricasan in the treatment of mild symptomatic individuals are highlighted by findings from a Phase 1 trial conducted in an outpatient environment.

Richard W. Pascoe, Histogen’s President, and Chief Executive Officer commented,

These excellent findings support emricasan’s substantial clinical safety record and clearly imply that it might be developed as a therapeutic therapy for mild to moderate COVID-19 and other viral inflammatory disorders. HSTO is excited to collaborate with their Amerimmune colleagues as they define a strategic route for emricasan’s clinical development choices and partnering prospects.

>> 7 Top Picks for the Post-Pandemic Economy << 

Dr. Oral Alpan, M.D. Chief Executive Officer of Amerimmune LLC commented,

The results revealed that the emricasan group had full and early remission of COVID-19-related symptoms, whereas the placebo group had symptoms that persisted. But, it offered significant insight into the illness process, which will be crucial in the development of COVID-19 treatment alternatives. They’re looking forward to collaborating with Histogen to bring Amerimmune’s skills to the emricasan research program as an example of how physician-owned diagnostic laboratories may be the source of medical discoveries and actively engage in the development of innovative treatments.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

Smith Micro Develops Inc. (SMSI) stock soars during current market trading. Here’s to know why?

Smith Micro Develops Inc. (NASDAQ: SMSI) stock surged by 2.39% during the current market trading session. Smith Micro creates software that simplifies and improves...

Drive Shack Inc. (DS) stock soars during after-hour trading, followed by no recent update

Drive Shack Inc. (NASDAQ: DS) stock declined by 3.94% at last close while the DS stock-price surged by 7.38% in the after-hour session. Drive...

SPX Flow Inc. (FLOW) stock surged during current market. Here’s why the stock is sky-rocketing?

SPX Flow Inc. (NASDAQ: FLOW) stock gained by 24.24% in the current market trading session. SPX FLOW, based in Charlotte, works to make the...

Platinum Group Metal Ltd. (PLG) stock surges during after-market trading. Here’s to know what’s happening?

Platinum Group Metal Ltd. (NASDAQ: PLG) stock declined by 8.54% at last close whereas the PLG stock price gains by 7% in the after-market...

TD Holdings Inc. (GLG) stock gains during current market trading. Here’s the recent update

TD Holdings Inc. (NASDAQ: GLG) stock gains by 5.01% in the current market trading session. TD Holdings, Inc. is a service provider in China...

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

NeuroMetrix Inc. (NURO) stock plunged during pre-market. Let’s find out why?

NeuroMetrix Inc. (NASDAQ: NURO) stock gained by 18.89% at last close while the NURO stock price losses by -4.12% in the pre-market trading session....

Related News

Veoneer Inc. (VNE) stock shows massive gains during pre-market. What’s driving it high?

Veoneer Inc. (NASDAQ: VNE) stock decline by 1.82% at the last close whereas the VNE stock price gains by 55.19% in the pre-market trading...

AnPac Bio-Medical Sciences Inc. (ANPC) stock soars during pre-market. Here’s what you should know?

AnPac Bio-Medical Sciences Inc. (NASDAQ: ANPC) stock declined by 4.98% at last close however the ANPC stock price gains by 6.96% in the pre-market...

Endeavour Silver Corp. (EXK) stock surged during pre-market trading. Here’s what you should know?

Endeavour Silver Corp. (NASDAQ: EXK) stock declined by 4.97% at the last close whereas the EXK stock price gains by 3.56% in the pre-market...

Here is why Amneal Pharmaceuticals Inc (AMRX) stock soared on Monday?

Amneal Pharmaceuticals Inc. (AMRX) shares rose 7.18% in after-hours on Monday, July 19, 2021, and closed at $4.63 per share. Earlier in the morning,...

Why Applied DNA Sciences Inc. (APDN) stock had a bad Friday?

Applied DNA Sciences Inc. (APDN) shares fell 5.27% in after-hours on Friday, July 16, 2021, at $5.03 per share. Earlier, APDN's stock lost 2.93%...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam